4.7 Editorial Material

New drug approvals in acute myeloid leukemia: what's the best end point?

Journal

LEUKEMIA
Volume 30, Issue 3, Pages 521-525

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/leu.2015.262

Keywords

-

Funding

  1. NCI NIH HHS [R21 CA182010, CA182010] Funding Source: Medline
  2. Department of Health Funding Source: Medline

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available